Article
Active site remodeling switches HIV specificity of antiretroviral TRIMCyp.
Nature structural & molecular biology - 1 Oct 2009
Price Amanda J, Marzetta Flavia, Lammers Michael, Ylinen Laura M J, Schaller Torsten, Wilson Sam J, Towers Greg J, James Leo C
Abstract excerpt
TRIMCyps are primate antiretroviral proteins that potently inhibit HIV replication. Here we describe how rhesus macaque TRIMCyp (RhTC) has evolved to target and restrict HIV-2. We show that the ancestral cyclophilin A (CypA) domain of RhTC targets HIV-2 capsid with weak affinity, which is strongly increased in RhTC by two mutations (D66N and R69H) at the expense of HIV-1 binding. These mutations disrupt a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
